These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


181 related items for PubMed ID: 12566898

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Ubiquitin proteasome pathway: implications and advances in cancer therapy.
    Shah SA, Potter MW, Callery MP.
    Surg Oncol; 2001; 10(1-2):43-52. PubMed ID: 11719028
    [Abstract] [Full Text] [Related]

  • 3. Ubiquitin proteasome inhibition and cancer therapy.
    Shah SA, Potter MW, Callery MP.
    Surgery; 2002 Jun; 131(6):595-600. PubMed ID: 12075171
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The proteasome as a target for cancer therapy.
    Voorhees PM, Dees EC, O'Neil B, Orlowski RZ.
    Clin Cancer Res; 2003 Dec 15; 9(17):6316-25. PubMed ID: 14695130
    [Abstract] [Full Text] [Related]

  • 8. Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs.
    Giuliano M, D'Anneo A, De Blasio A, Vento R, Tesoriere G.
    Ital J Biochem; 2003 Jun 15; 52(2):112-21. PubMed ID: 14677428
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
    Wang J, Sampath A, Raychaudhuri P, Bagchi S.
    Oncogene; 2001 Aug 02; 20(34):4740-9. PubMed ID: 11498796
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of apoptosis by the ubiquitin and proteasome pathway.
    Wójcik C.
    J Cell Mol Med; 2002 Aug 02; 6(1):25-48. PubMed ID: 12003667
    [Abstract] [Full Text] [Related]

  • 16. Proteasome inhibitors in cancer therapy: a novel approach to a ubiquitous problem.
    Landis-Piwowar KR.
    Clin Lab Sci; 2012 Aug 02; 25(1):38-44. PubMed ID: 22458048
    [Abstract] [Full Text] [Related]

  • 17. The role of p27Kip1 in proteasome inhibitor induced apoptosis.
    Drexler HC.
    Cell Cycle; 2003 Aug 02; 2(5):438-41. PubMed ID: 12963837
    [Abstract] [Full Text] [Related]

  • 18. The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.
    Chen D, Dou QP.
    Curr Protein Pept Sci; 2010 Sep 02; 11(6):459-70. PubMed ID: 20491623
    [Abstract] [Full Text] [Related]

  • 19. The proteasome: a new target for novel drug therapies.
    Elliott PJ, Ross JS.
    Am J Clin Pathol; 2001 Nov 02; 116(5):637-46. PubMed ID: 11710679
    [Abstract] [Full Text] [Related]

  • 20. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells.
    Pasquini LA, Besio Moreno M, Adamo AM, Pasquini JM, Soto EF.
    J Neurosci Res; 2000 Mar 01; 59(5):601-11. PubMed ID: 10686588
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.